"5" . "119032" . "2"^^ . . . . "\u010Cesk\u00E1 gynekologie" . "Zm\u011Bny lipid\u016F a lipoprotein\u016F prov\u00E1zej\u00EDc\u00ED fyziologick\u00E1 a rizikov\u00E1 t\u011Bhotenstv\u00ED"@cs . "Lipid and lipoprotein levels in normal and complicated pregnancies"@en . "2"^^ . "Zm\u011Bny lipid\u016F a lipoprotein\u016F prov\u00E1zej\u00EDc\u00ED fyziologick\u00E1 a rizikov\u00E1 t\u011Bhotenstv\u00ED"@cs . "Lipid and lipoprotein levels in normal and complicated pregnancies"@en . "RIV/00216275:25520/13:39897051!RIV14-MSM-25520___" . "1210-7832" . "Kokrdov\u00E1, Zuzana" . "CZ - \u010Cesk\u00E1 republika" . . . "pregnancy; metabolic syndrome; insulin resistance; hyperlipidaemia"@en . . . . . "[1DC66E74B5EB]" . "Zm\u011Bny lipid\u016F a lipoprotein\u016F prov\u00E1zej\u00EDc\u00ED fyziologick\u00E1 a rizikov\u00E1 t\u011Bhotenstv\u00ED" . "I" . "Ve studii jsou porovn\u00E1v\u00E1ny hladiny lipid\u016F a lipoprotein\u016F v pr\u016Fb\u011Bhu t\u011Bhotenstv\u00ED a po porodu u zdrav\u00FDch t\u011Bhotn\u00FDch \u017Een i u \u017Een s rizikov\u00FDm t\u011Bhotenstv\u00EDm v\u010Detn\u011B t\u011Bhotenstv\u00ED \u017Een s metabolick\u00FDm syndromem. Druh\u00E1 polovina t\u011Bhotenstv\u00ED je prov\u00E1zena hyperlipid\u00E9mi\u00ED a inzul\u00EDnovou rezistenc\u00ED. Fyziologick\u00E1 reakce na t\u011Bhotenstv\u00ED p\u0159edstavuje p\u0159echodnou exkurzi do metabolick\u00E9ho syndromu. P\u0159i srovn\u00E1n\u00ED jednotliv\u00FDch skupin t\u011Bhotn\u00FDch \u017Een jsme ve skupin\u011B t\u011Bhotn\u00FDch \u017Een s metabolick\u00FDm syndromem prok\u00E1zali nejni\u017E\u0161\u00ED, p\u0159esto signifikantn\u00ED zv\u00FD\u0161en\u00ED hladiny triglycerid\u016F v\u016F\u010Di net\u011Bhotn\u00FDm zdrav\u00FDm kontrol\u00E1m (p ? 0,001). Ve skupin\u011B \u017Een s metabolick\u00FDm syndromem, na rozd\u00EDl od ostatn\u00EDch skupin, nedo\u0161lo v pr\u016Fb\u011Bhu t\u011Bhotenstv\u00ED ke zv\u00FD\u0161en\u00ED celkov\u00E9ho ani LDL-cholesterolu. Naopak pr\u00E1v\u011B ve skupin\u011B \u017Een s metabolick\u00FDm syndromem byl prok\u00E1z\u00E1n signifikantn\u00ED pokles HDL-cholesterolu v\u016F\u010Di net\u011Bhotn\u00FDm zdrav\u00FDm kontrol\u00E1m 6 a 24 m\u011Bs\u00EDc\u016F po porodu (p ? 0,01, p ? 0,001)."@cs . "8"^^ . . . . "Lipid and lipoprotein levels during pregnancy and postpartum were compared in healthy pregnant women and in high risk pregnancy groups including women with pre-existing metabolic syndrome. The second half of a normal pregnany is accompanied by hyperlipidaemia and glucose intolerance. Physiological response to pregnancy represents a transient excursion into a metabolic syndrome. Total triglyceride levels in late gestation were at least but significantly (p ? 0.001) elevated above those in non-pregnant controls in the group of patiens with pre-existing metabolic syndrome. In the same group, in contrast with other groups, no changes in plasma cholesterol and LDL-cholesterol were found in late pregnancy. However, significant decline in HDL-cholesterol, when compared to non-pregnant controls, was observed 6 and 24 months postpartum only in the group of women with pre-existing metabolic syndrome (p?0.01, p ? 0.001respectively)."@en . "78" . "RIV/00216275:25520/13:39897051" . "Ko\u0161\u0165\u00E1l, Milan" . . . . "Ve studii jsou porovn\u00E1v\u00E1ny hladiny lipid\u016F a lipoprotein\u016F v pr\u016Fb\u011Bhu t\u011Bhotenstv\u00ED a po porodu u zdrav\u00FDch t\u011Bhotn\u00FDch \u017Een i u \u017Een s rizikov\u00FDm t\u011Bhotenstv\u00EDm v\u010Detn\u011B t\u011Bhotenstv\u00ED \u017Een s metabolick\u00FDm syndromem. Druh\u00E1 polovina t\u011Bhotenstv\u00ED je prov\u00E1zena hyperlipid\u00E9mi\u00ED a inzul\u00EDnovou rezistenc\u00ED. Fyziologick\u00E1 reakce na t\u011Bhotenstv\u00ED p\u0159edstavuje p\u0159echodnou exkurzi do metabolick\u00E9ho syndromu. P\u0159i srovn\u00E1n\u00ED jednotliv\u00FDch skupin t\u011Bhotn\u00FDch \u017Een jsme ve skupin\u011B t\u011Bhotn\u00FDch \u017Een s metabolick\u00FDm syndromem prok\u00E1zali nejni\u017E\u0161\u00ED, p\u0159esto signifikantn\u00ED zv\u00FD\u0161en\u00ED hladiny triglycerid\u016F v\u016F\u010Di net\u011Bhotn\u00FDm zdrav\u00FDm kontrol\u00E1m (p ? 0,001). Ve skupin\u011B \u017Een s metabolick\u00FDm syndromem, na rozd\u00EDl od ostatn\u00EDch skupin, nedo\u0161lo v pr\u016Fb\u011Bhu t\u011Bhotenstv\u00ED ke zv\u00FD\u0161en\u00ED celkov\u00E9ho ani LDL-cholesterolu. Naopak pr\u00E1v\u011B ve skupin\u011B \u017Een s metabolick\u00FDm syndromem byl prok\u00E1z\u00E1n signifikantn\u00ED pokles HDL-cholesterolu v\u016F\u010Di net\u011Bhotn\u00FDm zdrav\u00FDm kontrol\u00E1m 6 a 24 m\u011Bs\u00EDc\u016F po porodu (p ? 0,01, p ? 0,001)." . "25520" . . "Zm\u011Bny lipid\u016F a lipoprotein\u016F prov\u00E1zej\u00EDc\u00ED fyziologick\u00E1 a rizikov\u00E1 t\u011Bhotenstv\u00ED" . .